Correction: RhoC maintains vascular homeostasis by regulating VEGF-induced signaling in endothelial cells [J. Cell Sci., 128, (3556-3568)] doi:10.1242/jcs.167601;RhoC maintains vascular homeostasis by regulating VEGF-induced signaling in endothelial cells

Journal of Cell Science

Volumn 128, Issue 19, 2015, Pages 3556-3568

  Hoeppner, Luke H ^a,c   Sinha, Sutapa ^a   Wang, Ying ^a   Bhattacharya, Resham ^a,d   Dutta, Shamit ^a   Gong, Xun ^a   Bedell, Victoria M ^a   Suresh, Sandip ^a   Chun, Changzoon ^b,e   Ramchandran, Ramani ^b   Ekker, Stephen C ^a   Mukhopadhyay, Debabrata ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Endothelial cell; Migration; Permeability; Proliferation; RhoC; VEGF

Indexed keywords

BETA CATENIN; CALCIUM ION; CYCLIN D1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; MORPHOLINE DERIVATIVE; MORPHOLINO; PHOSPHOLIPASE C GAMMA; RHO FACTOR; RHOC PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOC PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL CYCLE PROGRESSION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; ZEBRA FISH; CELL CYCLE; CELL MOTION; ENDOTHELIUM CELL; GENETICS; IN SITU HYBRIDIZATION; METABOLISM; PHYSIOLOGY;

CELL CYCLE; CELL MOVEMENT; ENDOTHELIAL CELLS; HUMANS; IN SITU HYBRIDIZATION; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84946082846     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.217604     Document Type: Erratum

References (62)

1. Abraham, S., Yeo, M., Montero-Balaguer, M., Paterson, H., Dejana, E., Marshall, C. J. and Mavria, G. (2009). VE-Cadherin-mediated cell-cell interaction suppresses sprouting via signaling to MLC2 phosphorylation. Curr. Biol. 19, 668-674.
2. Adini, I., Rabinovitz, I., Sun, J. F., Prendergast, G. C. and Benjamin, L. E. (2003). RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development. Genes Dev. 17, 2721-2732.
3. Bellovin, D. I., Simpson, K. J., Danilov, T., Maynard, E., Rimm, D. L., Oettgen, P. and Mercurio, A. M. (2006). Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene 25, 6959-6967.
4. Bishop, A. L. and Hall, A. (2000). Rho GTPases and their effector proteins. Biochem. J. 348, 241-255.
5. 2++ and von Willebrand factor release in human endothelial cells. Am. J. Pathol. 138, 213-221.
6. Bryan, B. A., Dennstedt, E., Mitchell, D. C., Walshe, T. E., Noma, K., Loureiro, R., Saint-Geniez, M., Campaigniac, J.-P., Liao, J. K. and D'Amore, P. A. (2010). RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis. FASEB J. 24, 3186-3195.
7. Carmeliet, P. (2000). Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389-395.
8. Del Galdo, S., Vettel, C., Heringdorf, D. M. and Wieland, T. (2013). The activation of RhoC in vascular endothelial cells is required for the S1P receptor type 2-induced inhibition of angiogenesis. Cell. Signal. 25, 2478-2484.
9. Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R. and Zeiher, A. M. (1999). Activation of nitric oxide synthase in endothelial cells by Aktdependent phosphorylation. Nature 399, 601-605.
10. Eichmann, A. and Simons, M. (2012). VEGF signaling inside vascular endothelial cells and beyond. Curr. Opin. Cell Biol. 24, 188-193.
11. Gou, W.-F., Zhao, Y., Lu, H., Yang, X.-F., Xiu, Y.-L., Zhao, S., Liu, J.-M., Zhu, Z.-T., Sun, H.-Z., Liu, Y.-P. et al. (2014). The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cells. BMC Cancer 14, 477.
12. Granger, H. J., Ziche, M., Hawker, J. R., Jr, Meininger, C. J., Czisny, L. E. and Zawieja, D. C. (1994). Molecular and cellular basis of myocardial angiogenesis. Cell. Mol. Biol. Res. 40, 81-85.
13. Hakem, A., Sanchez-Sweatman, O., You-Ten, A., Duncan, G., Wakeham, A., Khokha, R. and Mak, T. W. (2005). RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev. 19, 1974-1979.
14. Hirata, K., Kikuchi, A., Sasaki, T., Kuroda, S., Kaibuchi, K., Matsuura, Y., Seki, H., Saida, K. and Takai, Y. (1992). Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J. Biol. Chem. 267, 8719-8722.
15. Hoeppner, L. H., Phoenix, K. N., Clark, K. J., Bhattacharya, R., Gong, X., Sciuto, T. E., Vohra, P., Suresh, S., Bhattacharya, S., Dvorak, A. M. et al. (2012). Revealing the role of phospholipase Cbeta3 in the regulation of VEGF-induced vascular permeability. Blood 120, 2167-2173.
16. Howe, G. A. and Addison, C. L. (2012). RhoB controls endothelial cell morphogenesis in part via negative regulation of RhoA. Vasc. Cell 4, 1.
17. Jalink, K., van Corven, E. J., Hengeveld, T., Morii, N., Narumiya, S. and Moolenaar, W. H. (1994). Inhibition of lysophosphatidate-and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho. J. Cell Biol. 126, 801-810.
18. 2+ influx. Circ. Res. 96, 1282-1290.
19. Johnson, D. G. and Walker, C. L. (1999). Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol. 39, 295-312.
20. Kawata, H., Kamiakito, T., Omoto, Y., Miyazaki, C., Hozumi, Y. and Tanaka, A. (2014). RhoC upregulation is correlated with reduced E-cadherin in human breast cancer specimens after chemotherapy and in human breast cancer MCF-7 cells. Hormones Cancer 5, 414-423.
21. Klemke, R. L., Cai, S., Giannini, A. L., Gallagher, P. J., de Lanerolle, P. and Cheresh, D. A. (1997). Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137, 481-492.
22. Lazarus, A. and Keshet, E. (2011). Vascular endothelial growth factor and vascular homeostasis. Proc. Am. Thorac. Soc. 8, 508-511.
23. Leung, T., Chen, X. Q., Manser, E. and Lim, L. (1996). The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol. Cell. Biol. 16, 5313-5327.
24. Liu, A.-X., Rane, N., Liu, J.-P. and Prendergast, G. C. (2001). RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells. Mol. Cell. Biol. 21, 6906-6912.
25. Malek, A. M. and Izumo, S. (1994). Molecular aspects of signal transduction of shear stress in the endothelial cell. J. Hypertens. 12, 989-999.
26. Matsumoto, T., Bohman, S., Dixelius, J., Berge, T., Dimberg, A., Magnusson, P., Wang, L., Wikner, C., Qi, J. H., Wernstedt, C. et al. (2005). VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO J. 24, 2342-2353.
27. Melendez, J., Stengel, K., Zhou, X., Chauhan, B. K., Debidda, M., Andreassen, P., Lang, R. A. and Zheng, Y. (2011). RhoA GTPase is dispensable for actomyosin regulation but is essential for mitosis in primary mouse embryonic fibroblasts. J. Biol. Chem. 286, 15132-15137.
28. Mitin, N., Rossman, K. L., Currin, R., Anne, S., Marshall, T. W., Bear, J. E., Bautch, V. L. and Der, C. J. (2013). The RhoGEF TEM4 regulates endothelial cell migration by suppressing actomyosin contractility. PLoS ONE 8, e66260.
29. Nakagawa, T., Li, J. H., Garcia, G., Mu, W., Piek, E., Böttinger, E. P., Chen, Y., Zhu, H. J., Kang, D.-H., Schreiner, G. F. et al. (2004). TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways. Kidney Int. 66, 605-613.
30. Nishiki, T., Narumiya, S., Morii, N., Yamamoto, M., Fujiwara, M., Kamata, Y., Sakaguchi, G. and Kozaki, S. (1990). ADP-ribosylation of the rho/rac proteins induces growth inhibition, neurite outgrowth and acetylcholine esterase in cultured PC-12 cells. Biochem. Biophys. Res. Commun. 167, 265-272.
31. Nishiyama, T., Sasaki, T., Takaishi, K., Kato, M., Yaku, H., Araki, K., Matsuura, Y. and Takai, Y. (1994). rac p21 is involved in insulin-induced membrane ruffling and rho p21 is involved in hepatocyte growth factor-and 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced membrane ruffling in KB cells. Mol. Cell. Biol. 14, 2447-2456.
32. Paterson, H. F., Self, A. J., Garrett, M. D., Just, I., Aktories, K. and Hall, A. (1990). Microinjection of recombinant p21rho induces rapid changes in cell morphology. J. Cell Biol. 111, 1001-1007.
33. Petzold, A. M., Bedell, V. M., Boczek, N. J., Essner, J. J., Balciunas, D., Clark, K. J. and Ekker, S. C. (2010). SCORE imaging: specimen in a corrected optical rotational enclosure. Zebrafish 7, 149-154.
34. Piekny, A., Werner, M. and Glotzer, M. (2005). Cytokinesis: welcome to the Rho zone. Trends Cell Biol. 15, 651-658.
35. Ridley, A. J. (1997). The GTP-binding protein Rho. Int. J. Biochem. Cell Biol. 29, 1225-1229.
36. Ridley, A. J. and Hall, A. (1992). The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70, 389-399.
37. Riento, K. and Ridley, A. J. (2003). Rocks: multifunctional kinases in cell behaviour. Nat. Rev. Mol. Cell Biol. 4, 446-456.
38. Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 671-674.
39. Risau, W. and Flamme, I. (1995). Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11, 73-91.
40. Rousseau, S., Houle, F., Kotanides, H., Witte, L., Waltenberger, J., Landry, J. and Huot, J. (2000). Vascular endothelial growth factor (VEGF)-driven actinbased motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase. J. Biol. Chem. 275, 10661-10672.
41. Salas-Vidal, E., Meijer, A. H., Cheng, X. and Spaink, H. P. (2005). Genomic annotation and expression analysis of the zebrafish Rho small GTPase family during development and bacterial infection. Genomics 86, 25-37.
42. Savagner, P. (2010). The epithelial-mesenchymal transition (EMT) phenomenon. Ann. Oncol. 21 Suppl. 7, vii89-vii92.
43. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S. and Dvorak, H. F. (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985.
44. Sequeira, L., Dubyk, C. W., Riesenberger, T. A., Cooper, C. R. and van Golen, K. L. (2008). Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis. Clin. Exp. Metastasis 25, 569-579.
45. Srinivasan, R., Zabuawala, T., Huang, H., Zhang, J., Gulati, P., Fernandez, S., Karlo, J. C., Landreth, G. E., Leone, G. and Ostrowski, M. C. (2009). Erk1 and Erk2 regulate endothelial cell proliferation and migration during mouse embryonic angiogenesis. PLoS ONE 4, e8283.
46. Sun, Z., Li, X., Massena, S., Kutschera, S., Padhan, N., Gualandi, L., SundvoldGjerstad, V., Gustafsson, K., Choy, W. W., Zang, G. et al. (2012). VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J. Exp. Med. 209, 1363-1377.
47. Tahir, S. A., Park, S. and Thompson, T. C. (2009). Caveolin-1 regulates VEGFstimulated angiogenic activities in prostate cancer and endothelial cells. Cancer Biol. Ther. 8, 2284-2294.
48. Takahashi, T., Yamaguchi, S., Chida, K. and Shibuya, M. (2001). A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J. 20, 2768-2778.
49. Takaishi, K., Sasaki, T., Kato, M., Yamochi, W., Kuroda, S., Nakamura, T., Takeichi, M. and Takai, Y. (1994). Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility. Oncogene 9, 273-279.
50. Thisse, C. and Thisse, B. (2008). High-resolution in situ hybridization to wholemount zebrafish embryos. Nat. Protoc. 3, 59-69.
51. Treins, C., Giorgetti-Peraldi, S., Murdaca, J. and Van Obberghen, E. (2001). Regulation of vascular endothelial growth factor expression by advanced glycation end products. J. Biol. Chem. 276, 43836-43841.
52. Uehata, M., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T., Morishita, T., Tamakawa, H., Yamagami, K., Inui, J., Maekawa, M. et al. (1997). Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389, 990-994.
53. Van Aelst, L. and D'Souza-Schorey, C. (1997). Rho GTPases and signaling networks. Genes Dev. 11, 2295-2322.
54. van Golen, K. L., Wu, Z.-F., Qiao, X. T., Bao, L. and Merajver, S. D. (2000). RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells. Neoplasia 2, 418-425.
55. van Nieuw Amerongen, G. P., Koolwijk, P., Versteilen, A. and van Hinsbergh, V. W. M. (2003). Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler. Thromb. Vasc. Biol. 23, 211-217.
56. Voelkel, N. F. and Tuder, R. M. (2000). Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J. Clin. Invest. 106, 733-738.
57. Wang, W., Wu, F., Fang, F., Tao, Y. and Yang, L. (2008). RhoC is essential for angiogenesis induced by hepatocellular carcinoma cells via regulation of endothelial cell organization. Cancer Sci. 99, 2012-2018.
58. Wheeler, A. P. and Ridley, A. J. (2004). Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp. Cell Res. 301, 43-49.
59. Willmer, T., Contu, L., Blatch, G. L. and Edkins, A. L. (2013). Knockdown of Hop downregulates RhoC expression, and decreases pseudopodia formation and migration in cancer cell lines. Cancer Lett. 328, 252-260.
60. Wu, H. M., Yuan, Y., Zawieja, D. C., Tinsley, J. and Granger, H. J. (1999). Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability. Am. J. Physiol. 276, H535-H542.
61. Zeng, H., Sanyal, S. and Mukhopadhyay, D. (2001). Tyrosine residues951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively. J. Biol. Chem. 276, 32714-32719.
62. Zeng, H., Zhao, D. and Mukhopadhyay, D. (2002). KDR stimulates endothelial cell migration through heterotrimeric G protein Gq/11-mediated activation of a small GTPase RhoA. J. Biol. Chem. 277, 46791-46798.